Determination of cut-off titers and agreement between immunofluorescence and immunoblotting methods for detecting antinuclear antibodies in children

Journal of Clinical Laboratory Analysis

Volumn 24, Issue 4, 2010, Pages 230-236

  Aksu, G ^a   Gulez, N ^a   Azarsiz, E ^a   Karaca, N ^a   Kutukculer N ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

ANA; Children; Cut off titer; Immunoblotting; Immunoflourescence

Indexed keywords

ANTIGEN; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; DOUBLE STRANDED DNA ANTIBODY; HISTONE ANTIBODY; LA ANTIBODY; RO ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CHILDHOOD DISEASE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; COST; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; KAPPA STATISTICS; MAJOR CLINICAL STUDY; MALE; REFERENCE VALUE; SCHOOL CHILD;

ANTIBODIES, ANTINUCLEAR; CHI-SQUARE DISTRIBUTION; CHILD; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOBLOTTING; MALE; REFERENCE VALUES;

EID: 77955646497     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20391     Document Type: Article

References (25)

1. Tan EM, Feltkamp TEW, Smolen JS. Range of antinuclear antibodies in "healthy" individiuals. Arthritis Rheum 1997;40:1601.
2. Kumar Y, Bhatia A, Minz RW. Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: A journey revisited. Diagn Pathol 2009;4:1.
3. Muro Y. Antinuclear antibodies. Autoimmunity 2005;38:3-9.
4. Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med 2000;124:71-81. (Pubitemid 30053777)
5. Hayashi N, Kawamoto T, Mukai M, et al. Detection of antinuclear antibodies by use of an enzyme immunoassay with nuclear Hep 2 cell extract and recombinant antigens: Comparison with immunofluorescence assay in 307 patients. Clin Chem 2001;47:1649-1659. (Pubitemid 32781579)
6. Gonzalez C, Martin T, Arroyo, T, Isidoro MG, Navajo J, Buitrago JMG. Comparison and variation of different methodologies for the detection of autoantibodies to nuclear antigens (ANA). J Clin Lab Anal 1997;11:388-392. (Pubitemid 27513675)
7. Griesmacher A, Peichl. Autoantibodies associated with rheumatic diseases. Clin Chem Lab Med 2001;39:189-208.
8. Eissfeller P, Sticherling M, Scholz D, et al. Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases. Ann N Y Acad Sci 2005;1050:327-339. (Pubitemid 41129451)
9. Thomas C, Robinson JA. The antinuclear antibody test. When is a positive result clinically relevant? Postgrad Med 1993;94:55-66.
10. Peene I, Meheus L, Veys EM, De Keyser F. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 2001;60:1131-1136. (Pubitemid 33096077)
11. Bonaguri C, Melegari A, Dall'aglio P, et al. An Italian multicenter study for application of a diagnostic algorithm in autoantibody testing. Ann N Y Acad Sci 2009;1173:124-129.
12. Ghosh P, Duvivedi S, Naik S, et al. Antinuclear antibodies by indirect immunofluorescence: Optimum screening dilution for diagnosis of systemic lupus erythematosus. Indian J Med Res 2007;126:34-38. (Pubitemid 350020545)
13. Sack U, Conrad K, Csernok E, et al. Autoantibody detection using indirect immunofluorescence on hep 2 cells. Ann N Y Acad Sci 2009;1173:166-173.
14. Mcghee JL, Kickingbird LM, Jarvis JN. Clinical utility of antinuclear antibody tests in children. BMC Pediatr 2004;4:13.
15. Hilario MOE, Len CA, Roja SC, Terreri MT, Almeida G, Andrade LEC. Frequency of antinuclear antibodies in healthy children and adolescents. Clin Pediatr (Phila) 2004;43:637.
16. Egner W. The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 2000;53:424.
17. Kern P, Kron M, Hiesche K. Measurement of antinuclear antibodies: Assessment of different test systems. Clin Diagn Lab Immunol 2000;7:72-78. (Pubitemid 30051465)
18. Bagnasco M, Grassia L, Pesce G. The management of the patient with unexpected autoantibody positivity. Autoimmun Rev 2007;6:347-353. (Pubitemid 46810403)
19. Bizzaro N, Tozzoli R, Tanutti E, et al. Variability between methods to determine ANA, anti-dsDNA and anti-ENA antibodies; a collaborative study with the biomedical industry. J Immunol Methods 1998;219:99-107. (Pubitemid 28513155)
20. Hoffman IEA, Peene I, Veys EM, Keyser FD. Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests. Clin Chem 2002;48:2171-2176. (Pubitemid 35397559)
21. Kang I, Siperstein R, Quan T, Breitenstein ML. Utility of age, gender, ANA titer and pattern as predictors of anti-ENA anddsDNA antibodies. Clin Rheumatol 2004;23:509-515. (Pubitemid 39562257)
22. Perilloux BC, Shetty AK, Leiva LE, Gedalia A. Antinuclear antibody (ANA) and ANA profile tests in children with autoimmune disorders; a retrospective study. Clin Rheumatol 2000;19:200-203. (Pubitemid 30341253)
23. Hauksdottir GS, Jonsson T, Mellbye OJ. Antinuclear antibody (ANA) profile testing of ANA positive patients. Clin Rheumatol 2001;20:157-158. (Pubitemid 32401298)
24. Keech CL, Mccluskey J, Gordon TP. Transfection and overexpression of the human 60 Kda Ro/SS-A autoantigen in Hep-2 cells. Clin Immunol Immunopathol 1994;73:146-151.
25. Pourmand N, Blomberg S, Rönblomm L, Karlsson-Parra A, Petterson I, Wahren- Herlenius M. Ro 52kD autoantibodies are detected in a subset of ANA negative sera. Scand J Rheumatol 2000;29:116-123. (Pubitemid 30434154)